Cargando…
TMEM106B, a risk factor for FTLD and aging, has an intrinsically disordered cytoplasmic domain
TMEM106B was initially identified as a risk factor for FTLD, but recent studies highlighted its general role in neurodegenerative diseases. Very recently TMEM106B has also been characterized to regulate aging phenotypes. TMEM106B is a 274-residue lysosomal protein whose cytoplasmic domain functions...
Autores principales: | Kang, Jian, Lim, Liangzhong, Song, Jianxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192649/ https://www.ncbi.nlm.nih.gov/pubmed/30332472 http://dx.doi.org/10.1371/journal.pone.0205856 |
Ejemplares similares
-
Loss of TMEM106B potentiates lysosomal and FTLD‐like pathology in progranulin‐deficient mice
por: Werner, Georg, et al.
Publicado: (2020) -
A unified mechanism for LLPS of ALS/FTLD-causing FUS as well as its modulation by ATP and oligonucleic acids
por: Kang, Jian, et al.
Publicado: (2019) -
AAV-GRN partially corrects motor deficits and ALS/FTLD-related pathology in Tmem106b(−/−)Grn(−/−) mice
por: Feng, Tuancheng, et al.
Publicado: (2023) -
A novel temporal‐predominant neuro‐astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS‐TDP
por: Llibre‐Guerra, Jorge J., et al.
Publicado: (2021) -
A 3’UTR Insertion Is a Candidate Causal Variant at the TMEM106B Locus Associated with Increased Risk for FTLD-TDP
por: Chemparathy, Augustine, et al.
Publicado: (2023)